OliX Pharmaceuticals,Inc (226950.KQ)
KRW 18430.0
(-6.07%)
KRW 18430.0
(-6.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -21.16 Billion | -30.68 Billion | -19.05 Billion | -3.75 Billion | -10.73 Billion | -8.35 Billion |
| Net Income | -19.1 Billion | -28.11 Billion | -29.17 Billion | -19.38 Billion | -14.35 Billion | -7.74 Billion |
| Depreciation & Amortization | 2.64 Billion | 1.97 Billion | 1.61 Billion | 1.19 Billion | 775.52 Million | 508.12 Million |
| Deferred income taxes | -11.07 Billion | -1.07 Billion | -1.81 Billion | -574.45 Million | -1.34 Billion | -677.61 Million |
| Stock-based compensation | 1.22 Billion | 1.43 Billion | 1.88 Billion | 512.8 Million | 1.07 Billion | 544.72 Million |
| Change in working capital | -7.15 Billion | -8.45 Billion | 2.36 Billion | 9.96 Billion | 1.58 Billion | -1.52 Billion |
| Other non-cash items | 12.29 Billion | 8.27 Billion | 9.51 Billion | 6.76 Billion | 2.65 Billion | 1.9 Billion |
| Investing Cash Flow | 34.36 Billion | -54.76 Billion | 17.2 Billion | -31.41 Billion | 12.59 Billion | -31.74 Billion |
| Investments in PPE | -8.95 Billion | -2.53 Billion | -26.28 Billion | -1.16 Billion | -1.07 Billion | -1.5 Billion |
| Acquisitions | 54.33 Million | 181.31 Million | 1.76 Billion | - | 11.95 Million | - |
| Investment purchases | -65.95 Billion | -119.37 Billion | -20.5 Billion | -88.22 Billion | -49.06 Billion | -48.89 Billion |
| Sales/Maturities of investments | 109.11 Billion | 68.26 Billion | 61.87 Billion | 58.53 Billion | 62.95 Billion | 18.7 Billion |
| Other Investing Activities | 114.85 Million | -1.29 Billion | 354.84 Million | -567.99 Million | -241.95 Million | -46.43 Million |
| Financing Cash Flow | -6.11 Billion | 56.04 Billion | 24.82 Billion | 41.66 Billion | 169.59 Million | 42.25 Billion |
| Debt repayment | -5.45 Billion | -57 Billion | -24.5 Billion | -28.99 Billion | -11.2 Million | -1.4 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 465.74 Million | -166.04 Million | 702.74 Million | 12.72 Billion | 211.87 Million | 43.65 Billion |
| Other Financing Activities | -118.9 Million | -166.04 Million | 1.73 Billion | -55.15 Million | 211.87 Million | 43.65 Billion |
| Accounts receivables | -4.75 Billion | -136.91 Million | -64.95 Million | 27.49 Million | -110.27 Million | 93.73 Million |
| Accounts payables | - | - | - | - | - | -674.66 Million |
| Inventory | 188.76 Million | -283.04 Million | -69.95 Million | 61.65 Million | 269.01 Million | 95.29 Million |
| Other working capital | -2.58 Billion | -8.03 Billion | 2.49 Billion | 9.87 Billion | 1.42 Billion | -1.03 Billion |
| Cash at beginning of period | 4.93 Billion | 34.33 Billion | 11.32 Billion | 4.95 Billion | 2.81 Billion | 678.04 Million |
| Cash at end of period | 11.98 Billion | 4.93 Billion | 34.33 Billion | 11.32 Billion | 4.95 Billion | 2.81 Billion |
| Capital Expenditure | -8.95 Billion | -2.53 Billion | -26.28 Billion | -1.16 Billion | -1.07 Billion | -1.5 Billion |
| Effect of forex changes on cash | -35.09 Million | -7.86 Million | 32.94 Million | -107.1 Million | 115.18 Million | -18.48 Million |
| Net cash flow / Change in cash | 7.05 Billion | -29.4 Billion | 23 Billion | 6.37 Billion | 2.14 Billion | 2.13 Billion |
| Free Cash Flow | -30.12 Billion | -33.21 Billion | -45.33 Billion | -4.92 Billion | -11.81 Billion | -9.86 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.58 Billion | -8.4 Billion | 3.19 Billion | -19.1 Billion | -4.92 Billion | -8.86 Billion |
| Depreciation & Amortization | 649.76 Million | 652.22 Million | 666.33 Million | 2.64 Billion | 667.31 Million | 669.06 Million |
| Deferred income taxes | - | - | -4.46 Billion | -11.07 Billion | -379.18 Million | -3.02 Billion |
| Stock-based compensation | 386.35 Million | 241.63 Million | -197.85 Million | 1.22 Billion | 334.12 Million | 536.88 Million |
| Change in working capital | -3.81 Billion | 2.48 Billion | -3.28 Billion | -7.15 Billion | -2.68 Billion | -266.21 Million |
| Other non-cash items | 8.77 Billion | -2.99 Billion | 3.25 Billion | 12.29 Billion | 2.77 Billion | 679.7 Million |
| Investing Cash Flow | -19.04 Billion | 11.68 Billion | 8.98 Billion | 34.36 Billion | 9.06 Billion | 5.71 Billion |
| Investments in PPE | -3.06 Billion | -2.08 Billion | -3.38 Billion | -8.95 Billion | -1.3 Billion | -2.5 Billion |
| Acquisitions | 110.2 Million | 4.65 Billion | -287.63 Thousand | 54.33 Million | 166.14 Thousand | 54.45 Million |
| Investment purchases | -30.12 Billion | -22.54 Billion | -12.39 Billion | -65.95 Billion | -22.79 Billion | -12.06 Billion |
| Sales/Maturities of investments | 13.99 Billion | 31.79 Billion | 23.88 Billion | 109.11 Billion | 33.99 Billion | 20.27 Billion |
| Other Investing Activities | 39.52 Million | -154.14 Million | 880.26 Million | 114.85 Million | -834.31 Million | -50 Million |
| Financing Cash Flow | -301.52 Million | 14.41 Billion | -3.15 Billion | -6.11 Billion | -2.74 Billion | -263.95 Million |
| Debt repayment | -298.63 Million | -14.7 Billion | -3 Billion | -5.45 Billion | -2.73 Billion | -263.34 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -2.89 Million | -2.85 Million | 41.73 Million | 465.74 Million | -6.03 Million | -605 Thousand |
| Other Financing Activities | -2.89 Million | -2.85 Million | -2.01 Million | -118.9 Million | -6.03 Million | -605 Thousand |
| Accounts receivables | -923.72 Million | 3.44 Billion | -3.55 Billion | -4.75 Billion | -425.77 Million | 2.3 Billion |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -20.09 Million | -304.59 Million | 228.95 Million | 188.76 Million | -16.59 Million | -4.66 Million |
| Other working capital | -2.86 Billion | -651.65 Million | 48.68 Million | -2.58 Billion | -2.24 Billion | -2.56 Billion |
| Cash at beginning of period | 31.65 Billion | 11.98 Billion | 7.02 Billion | 4.93 Billion | 6.68 Billion | 8.04 Billion |
| Cash at end of period | 6.09 Billion | 31.65 Billion | 11.98 Billion | 11.98 Billion | 7.02 Billion | 6.68 Billion |
| Capital Expenditure | -3.06 Billion | -2.08 Billion | -3.38 Billion | -8.95 Billion | -1.3 Billion | -2.5 Billion |
| Effect of forex changes on cash | 818.04 Thousand | 631.14 Thousand | -50.63 Million | -35.09 Million | -32.06 Million | 15.52 Million |
| Net cash flow / Change in cash | -25.56 Billion | 19.67 Billion | 4.95 Billion | 7.05 Billion | 344.58 Million | -1.36 Billion |
| Free Cash Flow | -9.28 Billion | -8.5 Billion | -4.21 Billion | -30.12 Billion | -7.25 Billion | -9.32 Billion |
JDW
1930
095660
EXE
ORAGF
HAMP